F
FIGS
Medical apparel of the highest quality
About FIGS
FIGS, Inc. is a dynamic startup that has carved a niche in the healthcare apparel market. The company is founder-led and operates on a direct-to-consumer (DTC) model, meaning it sells its products directly to customers without intermediaries. This approach allows FIGS to maintain control over its brand and customer experience while offering high-quality products at competitive prices.
Read full description
The primary focus of FIGS is on healthcare professionals, including doctors, nurses, and other medical staff. The company aims to celebrate and empower these individuals by providing them with technically advanced scrubs and other apparel. These products are designed to offer a unique blend of comfort, durability, function, and style, making them stand out in a market traditionally dominated by less innovative options.
FIGS operates in the healthcare apparel and lifestyle market, a sector that has seen increasing demand due to the growing number of healthcare professionals and the need for better workwear solutions. The company's business model is built around its DTC platform, which is the largest in the healthcare apparel industry. This platform enables FIGS to reach a rapidly growing community of loyal customers who appreciate the quality and functionality of its products.
Revenue generation for FIGS comes from the sale of its apparel and lifestyle products. By cutting out the middleman, the company can offer its products at more affordable prices while maintaining healthy profit margins. Additionally, FIGS leverages social media and other digital marketing strategies to build brand awareness and drive sales.
In summary, FIGS, Inc. is a forward-thinking company that is redefining healthcare apparel through innovation and a strong focus on customer needs. Its direct-to-consumer model and commitment to quality have positioned it as a leader in its market.
At a glance
- Founded
- 2010
- Headquarters
- Culver City, United States
- Listing
- IPO 2021
- Sector
- Health Tech & Medtech
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning FIGS.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Karlin Ventures
Crocs
500 Global
Mohr Davidow Ventures
Series A6 investors entered at this stage
Campfire Capital
Endeavor
Endeavor Catalyst
Cedars-Sinai Accelerator
Techstars
Tulco
Series B and later1 investor entered at this stage
- TUTulco
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about FIGS on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FIGS on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.